Successful inhibition of intracranial human glioblastoma multiforme xenograft growth via systemic adenoviral delivery of soluble endostatin and soluble vascular endothelial growth factor receptor-2: laboratory investigation
about
Anti-angiogenic gene therapy in the treatment of malignant gliomasInhibition of ovarian cancer by RGD-P125A-endostatin-Fc fusion proteins.Serum vascular endothelial growth factor receptor-2 and adropin levels in age-related macular degenerationStrategies in gene therapy for glioblastoma.Viruses, gene therapy and stem cells for the treatment of human glioma.Sitimagene ceradenovec: a gene-based drug for the treatment of operable high-grade glioma.Redirecting adenovirus tropism by genetic, chemical, and mechanical modification of the adenovirus surface for cancer gene therapy.Combination therapy targeting integrins reduces glioblastoma tumor growth through antiangiogenic and direct antitumor activity and leads to activation of the pro-proliferative prolactin pathway.AAV-P125A-endostatin and paclitaxel treatment increases endoreduplication in endothelial cells and inhibits metastasis of breast cancer.Secretion of soluble VEGF receptor 2 by microvascular endothelial cells derived by human benign prostatic hyperplasia.Regulation of soluble VEGFR-2 secreted by microvascular endothelial cells derived from human BPH.The corpora lutea proangiogenic state of VEGF system components is turned to antiangiogenic at the later phase of the oestrous cycle in cows.Gene therapy and targeted toxins for gliomaA Critical Overview of Targeted Therapies for Glioblastoma
P2860
Q26866276-24E50FA2-624C-42CC-B1D0-A3A984B533A5Q35164399-96D3596F-4375-47C7-9F96-0858BFC653FAQ36858963-2AAC4259-6BBF-41E2-90FA-45170ECA3C0FQ37420576-B0BC1882-6AA3-4E53-90F4-2C408F63D52FQ37567452-005324EB-221D-44CF-B39C-73D11B413230Q37818222-B383F877-BC5D-48D5-A3D6-F86F312BE9FDQ38769919-4D654A6A-C8D3-4423-9A2E-7CDAB9F820AAQ39060605-58D1ED01-81D7-48AF-8C5D-E2174400746AQ39655433-953A5900-4B77-4ACC-9F62-47F1E259C869Q39886654-B140BEBB-AC64-4076-AB59-32AF5118A9D2Q44479059-3D6B7263-935E-4DE3-8D5B-A8D29625D296Q54321577-362CDE34-6AEC-4424-AA60-3F55838745A4Q57006162-C651837B-5A3F-4CF0-AC8D-9BDFE3465172Q58122179-C54637C5-F177-46D9-A2EF-60BED0445CF3
P2860
Successful inhibition of intracranial human glioblastoma multiforme xenograft growth via systemic adenoviral delivery of soluble endostatin and soluble vascular endothelial growth factor receptor-2: laboratory investigation
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Successful inhibition of intra ...... or-2: laboratory investigation
@ast
Successful inhibition of intra ...... or-2: laboratory investigation
@en
type
label
Successful inhibition of intra ...... or-2: laboratory investigation
@ast
Successful inhibition of intra ...... or-2: laboratory investigation
@en
prefLabel
Successful inhibition of intra ...... or-2: laboratory investigation
@ast
Successful inhibition of intra ...... or-2: laboratory investigation
@en
P2093
P2860
P921
P356
P1476
Successful inhibition of intra ...... or-2: laboratory investigation
@en
P2093
Bob S Carter
Cheryl H Baker
Judah Folkman
Masaya Takahashi
Oszkar Szentirmai
Richard C Mulligan
Szofia S Bullain
P2860
P304
P356
10.3171/JNS/2008/108/5/0979
P577
2008-05-01T00:00:00Z